CEO, Staar Surgical
WHY: Ophthalmic device maker valued at $1.2B. Developed its first implantable lens to treat vision issues more than 30 years ago.
RECENT: Announced relocation of Staar from Monrovia to Lake Forest in April, to be closer to region’s hub of ophthalmic device makers, workers.
NOTABLE: Staar’s global sales jumped 37% to a record $124M in 2018, and forecast 2019 sales will grow 20% over 2018.
